Stay updated with breaking news from Bucher Biotec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Proteomics Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...
The Ionic Purification System uses isotachophoresis to extract nucleic acids from a wide range of sample types including cultured or sorted cells.
/PRNewswire/ -- The "Flow Cytometry Services Market by Type of General Flow Cytometric Services, Type of Analysis based Flow Cytometric Services, Other types...
Published: May 18, 2021 IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe. BRANFORD, Conn., May 18, 2021 /PRNewswire/ -- IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and Asian manufacturers of highly innovative life science research instrumentation, associated reagents, and consumables. This agreement follows Iso...
Share this article Share this article ResearchAndMarkets.com's offering. The 'Single-cell Sequencing Services and Technologies Market, 2020-2030' report features an extensive study of the current landscape and the future opportunities associated with single-cell sequencing services/technologies. One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as number of single-cell samples sequenced annually, average cost of sequencing, and growth trends across various geographies, ...